Back to Search Start Over

3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo.

Authors :
Rashidi H
Luu NT
Alwahsh SM
Ginai M
Alhaque S
Dong H
Tomaz RA
Vernay B
Vigneswara V
Hallett JM
Chandrashekran A
Dhawan A
Vallier L
Bradley M
Callanan A
Forbes SJ
Newsome PN
Hay DC
Source :
Archives of toxicology [Arch Toxicol] 2018 Oct; Vol. 92 (10), pp. 3117-3129. Date of Electronic Publication: 2018 Aug 28.
Publication Year :
2018

Abstract

Liver disease is an escalating global health issue. While liver transplantation is an effective mode of therapy, patient mortality has increased due to the shortage of donor organs. Developing renewable sources of human liver tissue is therefore attractive. Pluripotent stem cell-derived liver tissue represents a potential alternative to cadaver derived hepatocytes and whole organ transplant. At present, two-dimensional differentiation procedures deliver tissue lacking certain functions and long-term stability. Efforts to overcome these limiting factors have led to the building of three-dimensional (3D) cellular aggregates. Although enabling for the field, their widespread application is limited due to their reliance on variable biological components. Our studies focused on the development of 3D liver tissue under defined conditions. In vitro generated 3D tissues exhibited stable phenotype for over 1 year in culture, providing an attractive resource for long-term in vitro studies. Moreover, 3D derived tissue provided critical liver support in two animal models, including immunocompetent recipients. Therefore, we believe that our study provides stable human tissue to better model liver biology 'in the dish', and in the future may permit the support of compromised liver function in humans.

Details

Language :
English
ISSN :
1432-0738
Volume :
92
Issue :
10
Database :
MEDLINE
Journal :
Archives of toxicology
Publication Type :
Academic Journal
Accession number :
30155720
Full Text :
https://doi.org/10.1007/s00204-018-2280-2